Patrick Lam is currently a medicinal chemistry and drug discovery consultant at Lam Drug Discovery Consulting, LLC, and Distinguished Professor of Chemistry at Baruch S. Blumberg Institute, and Adjunct Professor at Drexel University College of Medicine. He retired from a chemistry director position of Bristol-Myers Squibb Co. Patrick joined DuPont in 1984 and moved to BMS in 2001. Patrick has >30 years of drug discovery experience. His expertise is in innovations in structure-based drug design, ADME-T, focused libraries, molecular recognition, and nucleic acid therapeutics to deliver biopharma clinical candidates with novel profiles.
Patrick received his Ph.D. from the University of Rochester (Dr. Louis Friedrich) and was a postdoctoral fellow at UCLA (Prof. Mike Jung and the late Prof. Don Cram, 1987 Nobel Laureate in chemistry). Patrick is the group leader/co-inventor of Eliquis(R), a novel anticoagulant. Eliquis(R) is currently one of the two top-selling small-molecule drugs in the world, with annual sales of ~US$9B.